Search
forLearn
5 / 801 resultslearn Haritaki
learn Shankh bhasm
learn Swertia Chirata Extract
learn Brahmi extract
Research
5 / 1000+ resultsresearch Effect of Gandharvahastadi Kwath in Virechana Krama in the Management of Thyroid Dysfunction
Ayurvedic treatment with Gandharvahastadi Kwath improved thyroid dysfunction symptoms.
research Effective Management of Pcos (Polycystic Ovarian Syndrome) through Ayurvedic Panchakarma Therapy Virechan : A Case Study
Ayurvedic Panchakarma therapy, Virechan, can effectively manage PCOS symptoms and improve health markers.
research MANAGEMENT OF INDRALUPTA- A CASE REPORT
Ayurvedic treatments successfully regrew hair and reduced hair loss in a woman with alopecia areata.
research The Ayurvedic Management in Graying of Hair
Ayurvedic treatment can reverse premature graying and improve hair health.
research A CONCEPTUAL REVIEW OF AYURVEDIC HERBAL AND MINERAL FORMULATIONS IN ARBUDA WITH SPECIAL REFERENCE TO CANCER
Ayurvedic remedies may boost immunity and balance in cancer treatment but need more research.
Community Join
5 / 1000+ resultscommunity Kintor long term safety phase 3
Kintor's phase III trial for pyri (KX-826) showed promising safety and efficacy results, with no drug-related sexual dysfunction reported. Users discussed their experiences with pyri, Minoxidil, Dutasteride, and concerns about the validity of the study results.
community Kintor KX -826 Pyrilutamide Adds 1 Year Phase 3 Trial For Safety
KX-826/pyrilutamide is undergoing an additional one-year safety and efficacy trial in China after a six-month study. Some participants speculate on the reasons for the extended trial and discuss the potential of other treatments.
community Kintor's email response to me, regarding false advertising, and my proposal for them to develop a topical dut formulation with meaningful efficacy.
Kintor apologized for using misleading images in their advertisements and promised stricter review processes. They are also considering developing a topical dutasteride formulation.
community Anagenic is trying to compound Gt20029
The conversation discusses concerns that Anagenic's version of GT20029 might not be as effective or safe as Kintor's, with comparisons to issues faced by pyrilutamide. The chemical structure of the drug has been published.
community Kintor Pharma Announces Completion of First Patient Enrollment in KX-826 Long-term Safety Phase III Trial for Treatment of AGA
Kintor Pharma has finished enrolling the first patient in a Phase III trial for KX-826, a treatment for androgenetic alopecia (AGA). One user has set a reminder to check back on the topic in a year.